THC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
THC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bad Debt Percentage of Revenue % can be used to estimate the company’s bad debt value. If the company’s bad debt percentage is from historical data, the metric can be used as an indicator of a company's receivable management ability. Under the requirements of transparency and accuracy, lower Bad Debt Percentage of Revenue is better.
The historical rank and industry rank for Tenet Healthcare's Bad Debt Percentage of Revenue % or its related term are showing as below:
The historical data trend for Tenet Healthcare's Bad Debt Percentage of Revenue % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenet HealthcareQuarterly Data | ||||||||||||||||||||||
Trend | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | ||
Bad Debt Percentage of Revenue % | Get a 7-Day Free Trial | |||||||||||||||||||||
Medicare Income Percentage of Revenue % | Get a 7-Day Free Trial | |||||||||||||||||||||
Medicaid Income Percentage of Revenue % | Get a 7-Day Free Trial | |||||||||||||||||||||
Occupancy Rate % | Get a 7-Day Free Trial | |||||||||||||||||||||
Managed Care Income Percentage of Revenue % | Get a 7-Day Free Trial | |||||||||||||||||||||
Change in Admissions % | Get a 7-Day Free Trial | |||||||||||||||||||||
Supplies Expense Percentage of Revenue % | Get a 7-Day Free Trial | |||||||||||||||||||||
Change in Equivalent Admissions % | Get a 7-Day Free Trial |
For the Medical Care Facilities subindustry, Tenet Healthcare's Bad Debt Percentage of Revenue %, along with its competitors' market caps and Bad Debt Percentage of Revenue % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Companies usually use Bad Debt Percentage of Revenue % to estimate their bad debt. The initial estimates of a company's bad debt allowance is typically based upon past performance. The formula is:
Bad Debt Percentage of Revenue % | = | ( Uncollectible sales | / | Revenue ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A bad debt expense is recognized when a receivable is no longer collectible because a customer is unable to fulfill their obligation to pay an outstanding debt due to bankruptcy or other financial problems.
The analysis of bad debt should be combined with the allowance and adjustment the company made of the fiscal year. If the company’s Bad Debt Percentage of Revenue % kept increasing, the company’s profitability should be questioned. However, abnormal low ratios are also worth attention because it may be a sign of fiscal report manipulation.
Thank you for viewing the detailed overview of Tenet Healthcare's Bad Debt Percentage of Revenue % provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard W Fisher | director | |
Roy Blunt | director | 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235 |
Paola M Arbour | officer: EVP, Chief Information Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Stephen H Rusckowski | director | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Thomas W Arnst | officer: EVP, Chief Admin. Officer & GC | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Tammy Romo | director | C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235 |
Daniel J Cancelmi | officer: Principal Accounting Officer | 13737 NOEL ROAD, SUITE 100, DALLAS TX 75240 |
J Robert Kerrey | director | NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036 |
Richard J Mark | director | 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103 |
Ronald A Rittenmeyer | director | 5400 LEGACY DRIVE, PLANO TX 75024 |
Lisa Y Foo | officer: EVP, Commercial Ops | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Audrey T. Andrews | officer: SVP and General Counsel | 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202 |
Meghan Fitzgerald | director | C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511 |
Howard Hacker | officer: EVP, Chief Compliance Officer | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
Marie Quintana | officer: EVP, Marketing/Communications | 14201 DALLAS PARKWAY, DALLAS TX 75254 |
From GuruFocus
By Business Wire • 06-23-2023
By Business Wire Business Wire • 04-27-2023
By Business Wire Business Wire • 11-15-2022
By Business Wire • 08-10-2023
By GuruFocus Research GuruFocus Editor • 02-18-2023
By Business Wire Business Wire • 10-24-2022
By GuruFocus Research • 11-15-2023
By Business Wire • 01-09-2024
By Business Wire • 12-13-2023
By GuruFocus Research • 10-11-2023